Literature DB >> 25827821

The evolving epidemiology of hepatocellular carcinoma: a global perspective.

Michael C Wallace1, David Preen, Gary P Jeffrey, Leon A Adams.   

Abstract

Primary liver cancer, the majority of which are hepatocellular carcinomas, is now the second leading cause of cancer death worldwide. Hepatocellular carcinoma is a unique cancer that typically arises in the setting of chronic liver disease at a rate dependent upon the complex interplay between the host, disease and environmental factors. Infection with chronic hepatitis B or C virus is currently the dominant risk factor worldwide. However, changing lifestyle and environmental factors in western countries plus rising neonatal hepatitis B vaccination rates and decreasing exposure to dietary aflatoxins in developing countries are driving an evolution of the epidemiology of this cancer. An understanding of this change is crucial in combating the rising incidence currently being seen in western regions and will underpin the efforts to reduce the mortality rates associated with this cancer.

Entities:  

Keywords:  chronic viral hepatitis; cirrhosis; epidemiology; hepatocellular carcinoma; nonalcoholic fatty liver disease

Mesh:

Year:  2015        PMID: 25827821     DOI: 10.1586/17474124.2015.1028363

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  122 in total

1.  Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Qiao-Sheng Huang; Hong-Liang Sun; Yao-Ting Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

2.  Percutaneous implantation of (125)iodine seeds for treatment of portal vein tumor thrombosis in hepatocellular carcinoma.

Authors:  Yan Liu; Ruibao Liu; Ping Wang; Shijie Li; Haiyang Shen
Journal:  Med Oncol       Date:  2015-07-08       Impact factor: 3.064

3.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

4.  Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.

Authors:  Michael C Wallace; Kenny Sek; Roslyn J Francis; Shaun Samuelson; John Ferguson; Jonathan Tibballs; Ali Asad; David B Preen; Gerry MacQuillan; George Garas; Leon A Adams; Gary P Jeffrey
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

Review 5.  Immune checkpoint inhibitors for hepatocellular carcinoma.

Authors:  Imane El Dika; Danny N Khalil; Ghassan K Abou-Alfa
Journal:  Cancer       Date:  2019-07-10       Impact factor: 6.860

Review 6.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

7.  The effect of hepatocellular carcinoma-associated fibroblasts on hepatoma vasculogenic mimicry.

Authors:  Qin She; Shuya Hu; Xia Pu; Qingxi Guo; Chunru Mou; Chengwan Yang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

8.  Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth.

Authors:  Nu T Lu; Natalie M Liu; James Q Vu; Darshil Patel; Whitaker Cohn; Joe Capri; Mary Ziegler; Nikita Patel; Angela Tramontano; Roger Williams; Julian Whitelegge; Samuel W French
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

9.  Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.

Authors:  Xuanlin Shen; Yuting Ding; Feng Lu; Haitao Yuan; Wenkang Luan
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi.

Authors:  Xiwen Liao; Chuangye Han; Wei Qin; Xiaoguang Liu; Long Yu; Sicong Lu; Zhiwei Chen; Guangzhi Zhu; Hao Su; Zengnan Mo; Xue Qin; Tao Peng
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.